Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$603.79 USD

603.79
924,883

+6.87 (1.15%)

Updated Oct 14, 2024 04:00 PM ET

After-Market: $603.80 +0.01 (0.00%) 6:44 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (96 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Patterson Companies (PDCO) Q1 Earnings Top Estimates, Up Y/Y

by Zacks Equity Research

Despite weak performance across Patterson Companies' (PDCO) Dental and Animal Health segments in the fiscal first quarter results, it benefited from aggressive cost savings measures.

Madeleine Johnson headshot

Bear of the Day: Illumina (ILMN)

by Madeleine Johnson

The coronavirus pandemic has dampened this medical stock's earnings and outlook.

Medtronic (MDT) Plans Up to $475M of Annual Cost Savings

by Zacks Equity Research

Medtronic (MDT) expects its new operating model to help it become more focused in terms of speeding up research and developments.

Is Thermo Fisher (TMO) a Great Growth Stock?

by Zacks Equity Research

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Thermo Fisher (TMO).

ResMed (RMD) Launches First CPAP Nasal Mask With Memory Foam

by Zacks Equity Research

ResMed (RMD) adds another product to its line of easy-to-use, convenient and comfortable masks.

Zacks.com featured highlights include: SGC, TMO, KR, WERN and ATVI

by Zacks Equity Research

Zacks.com featured highlights include: SGC, TMO, KR, WERN and ATVI

Phirbo's Product Mix Aids, Global Animal Health Business Ails

by Zacks Equity Research

Phirbo (PAHC) catered industries face issues like lack of processing availability and sudden drop in demand.

Medtronic's Pediatric Diabetes Device Gets Regulatory Nod

by Zacks Equity Research

MiniMed 770G is Medtronic's (MDT) MiniMed 670G System's upgraded version.

OMRI Clears NEOGEN's AquaPrime Peraside 15 as USDA Compliant

by Zacks Equity Research

NEOGEN (NEOG) completes organic certified water treatment program with the latest certification.

Syneos Health-Idorsia Collaborate to Launch Daridorexant in US

by Zacks Equity Research

Syneos Health (SYNH) inks deal with Idorsia to commercialize the treatment for insomnia in the United States.

What's in Store for Patterson Companies' (PDCO) Q1 Earnings?

by Zacks Equity Research

Patterson Companies' (PDCO) fiscal first-quarter results are likely to reflect sluggishness at Dental segment.

Here's Why You Should Invest in LHC Group (LHCG) Stock Now

by Zacks Equity Research

LHC Group (LHCG) continues to gain traction from its broad range of services, and strategic acquisitions and joint ventures.

Cooper Companies (COO) to Post Q3 Earnings: What's in Store?

by Zacks Equity Research

Cooper Companies' (COO) fiscal third-quarter performance is likely to reflect weak performance by CVI and CSI.

Medtronic's (MDT) Cryoablation Suited for Patients With PAF

by Zacks Equity Research

Medtronic's (MDT) cryoablation therapy's superiority for the treatment of PAF over currently available AAD treatment gets reflected in trial results.

Medtronic (MDT) Sees Trend Rebound Amid Coronavirus Crisis

by Zacks Equity Research

Medtronic's (MDT) procedure volumes start to recover in multiple markets globally.

Sweta Killa headshot

5 Solid Dividend Growth Stocks to Buy Now

by Sweta Killa

Dividend investing has been gaining immense popularity amid low rates and super-easy monetary policy.

Hologic Updates Breast Biopsy System to Enhance Workflow

by Zacks Equity Research

Hologic (HOLX) introduces features to update Brevera Breast Biopsy System in order to transform patient experience and enhance workflow.

Veeva Systems (VEEV) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Veeva Systems' (VEEV) core Subscription business segment performs impressively in Q2.

Bruker Rides on MALDI Launches Amid Coronavirus-Led Crisis

by Zacks Equity Research

For higher specific detection of the SARS-CoV-2 virus, Bruker (BRKR) launches luoroType SARS-CoV-2 plus next-generation 6-plex PCR assay.

    Phibro (PAHC) Q4 Earnings Fall Short of Estimates, Margins Up

    by Zacks Equity Research

    Phibro's (PAHC) core Animal Health segment was aided by the Osprey Biotechnics acquisition despite a dismal overall performance in Q4 due to pandemic-led business disruptions.

    AMN Healthcare's Advanced Mobile App to Aid Travel Clinicians

    by Zacks Equity Research

    AMN Healthcare's (AMN) new version of AMN Passport will benefit travel clinicians.

    Hologic's Acessa Health Buyout to Broaden GYN Surgical Line

    by Zacks Equity Research

    Hologic's (HOLX) newly-acquired product line is set to complement its market-leading MyoSure products for hysteroscopic removal of fibroids.

    Align Technology (ALGN) Strong on Robust Customer Adoption

    by Zacks Equity Research

    Align Technology (ALGN) treats the one millionth patient from the APAC region, highlighting the Invisalign system's continued adoption.

    Allscripts Enhances Healthcare Innovation With Patent Program

    by Zacks Equity Research

    Allscripts (MDRX) continues to advance healthcare innovation by earning five new application patents.

    Here's Why You Should Hold on to DENTSPLY (XRAY) Stock Now

    by Zacks Equity Research

    DENTSPLY (XRAY) continues to gain traction from its solid focus on R&D leading to product innovation, which continues to be a key catalyst.